The Enterprise Value as of November 2024 (TTM) for Checkpoint Therapeutics, Inc. (CKPT) is 175.79M

According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 175.79M. This represents a change of 155.96% compared to the average of 68.68M of the last 4 quarters.

Checkpoint Therapeutics, Inc. (CKPT) Historical Enterprise Value (quarterly & annually)

How has CKPT Enterprise Value performed in the past?

The mean historical Enterprise Value of Checkpoint Therapeutics, Inc. over the last ten years is 78.29M. The current 175.79M Enterprise Value has changed 22.36% with respect to the historical average. Over the past ten years (40 quarters), CKPT's Enterprise Value was at its highest in in the March 2017 quarter at 243.44M. The Enterprise Value was at its lowest in in the March 2015 quarter at 0.

Checkpoint Therapeutics, Inc. (CKPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Checkpoint Therapeutics, Inc. (CKPT) Average Enterprise Value

How has CKPT Enterprise Value performed in the past?

The current Enterprise Value of Checkpoint Therapeutics, Inc. (CKPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Checkpoint Therapeutics, Inc. (CKPT) Enterprise Value vs. Peers

How is CKPT’s Enterprise Value compared to its peers?

Checkpoint Therapeutics, Inc.’s Enterprise Value is greater than Mustang Bio, Inc. (7.08M), greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Fortress Biotech, Inc. (57.12M), less than Kodiak Sciences Inc. (201.31M), greater than Fortress Biotech, Inc. (57.12M), greater than Avenue Therapeutics, Inc. (1.25M), greater than Pieris Pharmaceuticals, Inc. (2.78M), greater than Aileron Therapeutics, Inc. (35.86M), greater than CytomX Therapeutics, Inc. (39.67M), greater than Instil Bio, Inc. (165.40M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (-8426888.00), greater than Assembly Biosciences, Inc. (68.59M), greater than Achilles Therapeutics plc (-38865958.00), greater than Cue Biopharma, Inc. (41.71M), greater than Medicenna Therapeutics Corp. (-25687000.00), less than XOMA Corporation (332.73M), greater than ZIVO Bioscience, Inc. (73.95M), greater than Lumos Pharma, Inc. (23.89M),

Build a custom stock screener for Checkpoint Therapeutics, Inc. (CKPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Checkpoint Therapeutics, Inc. (CKPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.